Vertex Pharmaceuticals Inc
BMV:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
Aena SME SA
OTC:ANNSF
|
ES |
|
S
|
Siemens AG
XBER:SIE
|
DE |
|
Aena SME SA
F:A441
|
ES |
|
C
|
China Construction Bank Corp
OTC:CICHY
|
CN |
|
C
|
Ciena Corp
LSE:0HYA
|
US |
Wall St Price Targets
VRTX Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VRTX is 9 321.07 MXN with a low forecast of 5 539.21 MXN and a high forecast of 11 185.62 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRTX's stock price target?
Price Target
9 321.07
MXN
According to Wall Street analysts, the average 1-year price target for VRTX is 9 321.07 MXN with a low forecast of 5 539.21 MXN and a high forecast of 11 185.62 MXN.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
